Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC503872PMC
http://dx.doi.org/10.1136/hrt.16.1.93DOI Listing

Publication Analysis

Top Keywords

thrombo-embolic primary
4
primary pulmonary
4
pulmonary arteriosclerosis
4
thrombo-embolic
1
pulmonary
1
arteriosclerosis
1

Similar Publications

Introduction: Various cardiovascular thrombo-embolic clinical entities use combined ATS for prevention and treatment. After PCI, AF patients are typically prescribed DOAC, DAPT/SAPT, as component of ATS to minimize stroke risk and treat pulmonary embolism and venous thromboembolism. Some small observational studies have shown that a combined ATS can clear small thrombi in LV dysfunction and/or apical aneurysms.

View Article and Find Full Text PDF
Article Synopsis
  • Traumatic brain injury (TBI) is a serious health issue worldwide, leading to high rates of death and long-term disability, prompting exploration into treatments like tranexamic acid (TXA) for potential benefits.
  • This systematic review analyzed data from 12 randomized controlled trials (RCTs) with nearly 37,500 patients, focusing on TXA's effects on overall mortality and complications like DVT and stroke in TBI patients.
  • Results showed that TXA significantly reduced total mortality compared to placebo without increasing risks for thromboembolic events, and there were no significant differences in the need for neurosurgery or other major complications.
View Article and Find Full Text PDF

Background: We conducted a volume-outcome (V-O) meta-analysis of PEA procedures for chronic thromboembolic pulmonary hypertension (CTEPH), to objectively determine the minimum required annual case load that can define a high-volume centre.

Methods: Three electronic databases were systematically queried until May 1st, 2024. Centres were divided in volume tertiles (Ts).

View Article and Find Full Text PDF

Ability of Activated Clotting Time Measurements to Monitor Unfractionated Heparin Activity During NonCardiac Arterial Procedures.

Ann Vasc Surg

January 2025

Department of Vascular Surgery, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands; Department of Vascular Surgery, Dijklander Ziekenhuis, Hoorn, The Netherlands; Amsterdam Cardiovascular Sciences, Microcirculation, Amsterdam, The Netherlands. Electronic address:

Background: Activated clotting time (ACT) measurements are frequently used to monitor unfractionated heparin activity during noncardiac arterial procedures (NCAP). Accuracy of ACT-guided heparinization is mandatory to prevent heparin under and overdosing, thereby minimizing thrombo-embolic complications (TECs) and bleeding risk. The main objective of this study was to investigate accuracy of ACT to monitor heparin activity during NCAP using the Hemostasis Management System Plus (HMS) with high-range (HR) cartridges.

View Article and Find Full Text PDF

Purpose: Previous studies have shown that activated clotting time (ACT)-guided heparinization leads to better anticoagulation levels during noncardiac arterial procedures (NCAP) than a standardized bolus of 5000 IU. Better anticoagulation should potentially result in lower incidence of thrombo-embolic complications (TEC). Comparative investigations on clinical outcomes of these heparinization strategies are scarce.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!